跳至主要内容
临床试验/DRKS00022930
DRKS00022930尚未招募不适用

Study to identify blood-derived biomarkers indicative for initiation and progression of X-linked adrenoleukodystrophy

Center for Brain Research, Medical University of Vienna0 个研究点目标入组 400 人开始时间: 2020年8月24日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
3 Years 至 70 Years(—)
性别
All

入选标准

  • Inclusion criteria for plasma/serum remnant samples from X-ALD patients are:
  • 1) diagnosis of X-ALD by measurement of very long-chain fatty acids in the blood
  • 2) patient details (sex and age) are known at time of blood donation
  • 3) available data on the clinical course of the disease
  • 4) knowledge on medication and supplementation of the patient
  • Inclusion criteria for plasma/serum remnant samples from healthy controls are:
  • 1) patient details (sex and age) are known at time of blood donation
  • 2) no diagnosis of X-ALD or other disorders associated with neurodegeneration or neuroinflammation

排除标准

  • Exclusion criteria for plasma/serum remnant samples from X-ALD patients and controls are:
  • Intake of lipid lowering and anti-inflammatory medication

研究者

发起方
Center for Brain Research, Medical University of Vienna

相似试验